Humanized PD-1 knock-in mice as a model system for combination therapies with human specific PD-1 therapeutics

被引：0
|
作者：
Metzger, Philipp
Sonega, Fabiane
Berthomme, Herve
Obodozie, Cynthia
Weber, Holger
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5194
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5194
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters
    Nishi, Wataru
    Wakamatsu, Ei
    Machiyama, Hiroaki
    Matsushima, Ryohei
    Saito, Kensho
    Yoshida, Yosuke
    Nishikawa, Tetsushi
    Takehara, Tomohiro
    Toyota, Hiroko
    Furuhata, Masae
    Nishijima, Hitoshi
    Takeuchi, Arata
    Azuma, Miyuki
    Suzuki, Makoto
    Yokosuka, Tadashi
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade
    Lee, Bo Ryeong
    Chae, Sehyun
    Moon, Jihyun
    Kim, Myeong Joon
    Lee, Hankyu
    Ko, Hyuk Wan
    Cho, Byoung Chul
    Shim, Hyo Sup
    Hwang, Daehee
    Kim, Hye Ryun
    Ha, Sang-Jun
    JCI INSIGHT, 2020, 5 (14)
  • [33] Oncolytic virus and PD-1/PD-L1 blockade combination therapy
    Chen, Chun-Yu
    Hutzen, Brian
    Wedekind, Mary F.
    Cripe, Timothy P.
    ONCOLYTIC VIROTHERAPY, 2018, 7 : 65 - 77
  • [34] GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
    Jiang, Wenbo
    Chu, Xuebin
    Song, Lei
    Li, Xue
    Xue, Weili
    Li, Lingyun
    Zhao, Ranran
    Gu, Fei
    Xu, John
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [35] The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
    Shogo Kumagai
    Yosuke Togashi
    Takahiro Kamada
    Eri Sugiyama
    Hitomi Nishinakamura
    Yoshiko Takeuchi
    Kochin Vitaly
    Kota Itahashi
    Yuka Maeda
    Shigeyuki Matsui
    Takuma Shibahara
    Yasuho Yamashita
    Takuma Irie
    Ayaka Tsuge
    Shota Fukuoka
    Akihito Kawazoe
    Hibiki Udagawa
    Keisuke Kirita
    Keiju Aokage
    Genichiro Ishii
    Takeshi Kuwata
    Kenta Nakama
    Masahito Kawazu
    Toshihide Ueno
    Naoya Yamazaki
    Koichi Goto
    Masahiro Tsuboi
    Hiroyuki Mano
    Toshihiko Doi
    Kohei Shitara
    Hiroyoshi Nishikawa
    Nature Immunology, 2020, 21 : 1346 - 1358
  • [36] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [37] PD-1 Blockade in Chronically HIV-1-Infected Humanized Mice Suppresses Viral Loads
    Seung, Edward
    Dudek, Timothy E.
    Allen, Todd M.
    Freeman, Gordon J.
    Luster, Andrew D.
    Tager, Andrew M.
    PLOS ONE, 2013, 8 (10):
  • [38] The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
    Kumagai, Shogo
    Togashi, Yosuke
    Kamada, Takahiro
    Sugiyama, Eri
    Nishinakamura, Hitomi
    Takeuchi, Yoshiko
    Vitaly, Kochin
    Itahashi, Kota
    Maeda, Yuka
    Matsui, Shigeyuki
    Shibahara, Takuma
    Yamashita, Yasuho
    Irie, Takuma
    Tsuge, Ayaka
    Fukuoka, Shota
    Kawazoe, Akihito
    Udagawa, Hibiki
    Kirita, Keisuke
    Aokage, Keiju
    Ishii, Genichiro
    Kuwata, Takeshi
    Nakama, Kenta
    Kawazu, Masahito
    Ueno, Toshihide
    Yamazaki, Naoya
    Goto, Koichi
    Tsuboi, Masahiro
    Mano, Hiroyuki
    Doi, Toshihiko
    Shitara, Kohei
    Nishikawa, Hiroyoshi
    NATURE IMMUNOLOGY, 2020, 21 (11) : 1346 - +
  • [39] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [40] In vivo efficacy and safety evaluation of anti-human PD-1 and CD40 mAbs using double humanized PD-1/CD40 mouse model
    Guo, Yanan
    CANCER RESEARCH, 2019, 79 (13)
12345